| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 14, 2019Q2 revenue reflects increase over Q1, as US sales of mosquito abatement products and AgBio primer design services gain momentum
Salt Lake City, Utah – August 14, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Aug 1, 2019Company’s booth will promote infectious disease products and technology applications for NGS, liquid biopsy, and SNP differentiation
Salt Lake City, Utah – August 1, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jul 30, 2019
Salt Lake City, Utah – July 30, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jul 18, 2019
Salt Lake City, Utah – July 18, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jul 11, 2019
Salt Lake City, Utah – July 11, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jun 27, 2019
Salt Lake City, Utah – June 27, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jun 25, 2019
Salt Lake City, Utah – June 25, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
May 22, 2019
Salt Lake City, Utah – May 22, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
May 15, 2019
Salt Lake City, Utah – May 15, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Apr 30, 2019Method includes proprietary, single-step closed-tube NGS library prep in 3 hours or less
Salt Lake City, Utah – April 30, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...